In last trading session, Moleculin Biotech Inc (NASDAQ:MBRX) saw 0.43 million shares changing hands with its beta currently measuring 1.65. Company’s recent per share price level of $0.82 trading at -$0.05 or -5.60% at ring of the bell on the day assigns it a market valuation of $11.58M. That closing price of MBRX’s stock is at a discount of -620.73% from its 52-week high price of $5.91 and is indicating a premium of 51.22% from its 52-week low price of $0.40. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.64 million shares which gives us an average trading volume of 5.71 million if we extend that period to 3-months.

Moleculin Biotech Inc (NASDAQ:MBRX) trade information

Upright in the red during last session for losing -5.60%, in the last five days MBRX remained trading in the red while hitting it’s week-highest on Tuesday, 04/01/25 when the stock touched $0.82 price level, adding 21.15% to its value on the day. Moleculin Biotech Inc’s shares saw a change of -51.76% in year-to-date performance and have moved -21.15% in past 5-day. Moleculin Biotech Inc (NASDAQ:MBRX) showed a performance of -25.45% in past 30-days. Number of shares sold short was 0.46 million shares which calculate 0.04 days to cover the short interests.

Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 26.36% during past 5 years. In 2025, company’s earnings growth rate is likely to be around 73.47% while estimates for its earnings growth in next 5 years are of 37.81%.

Moleculin Biotech Inc (NASDAQ:MBRX)’s Major holders

Insiders are in possession of 0.72% of company’s total shares while institution are holding 3.32 percent of that, with stock having share float percentage of 3.34%. Investors also watch the number of corporate investors in a company very closely, which is 3.32% institutions for Moleculin Biotech Inc that are currently holding shares of the company.

On the other hand, VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund and Fidelity Concord Street Trust-Fidelity Extended Market Index Fund are the top two Mutual Funds which own company’s shares. As of Dec 31, 2024 , the former fund manager was holding 30.31 shares of worth $24857.0 or 0.23% of the total outstanding shares. The later fund manager was in possession of 14.36 shares on Feb 28, 2025 , making its stake of worth around $11772.0 in the company or a holder of 0.11% of company’s stock.